0001127602-24-018325.txt : 20240610
0001127602-24-018325.hdr.sgml : 20240610
20240610215810
ACCESSION NUMBER: 0001127602-24-018325
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240607
FILED AS OF DATE: 20240610
DATE AS OF CHANGE: 20240610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farrell Michael J.
CENTRAL INDEX KEY: 0001485164
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15317
FILM NUMBER: 241034520
MAIL ADDRESS:
STREET 1: C/O REMED INC
STREET 2: 9001 SPECTRUM CTR. BLVD.
CITY: SAN DIEGO,
STATE: CA
ZIP: 92123
FORMER NAME:
FORMER CONFORMED NAME: Farrell Michael
DATE OF NAME CHANGE: 20100224
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RESMED INC
CENTRAL INDEX KEY: 0000943819
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 980152841
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 9001 SPECTRUM CENTER BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92123
BUSINESS PHONE: 8587462400
MAIL ADDRESS:
STREET 1: 9001 SPECTRUM CENTER BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92123
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-06-07
0000943819
RESMED INC
RMD
0001485164
Farrell Michael J.
RESMED INC.
9001 SPECTRUM CENTER BLVD
SAN DIEGO
CA
92123
1
Chief Executive Officer
1
ResMed Common Stock
2024-06-07
4
M
0
14683
84.98
A
455482
D
ResMed Common Stock
2024-06-07
4
S
0
14683
211.6556
D
440799
D
ResMed Common Stock
0
I
Lisette and Michael Farrell Foundation
ResMed Common Stock
4090
I
Lisette and Michael Farrell Family Trust
ResMed Common Stock Options
84.98
2024-06-07
4
M
0
14683
0
D
2018-11-11
2024-11-16
ResMed Common Stock
14683
73415
D
The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.
This transaction was executed in multiple trades at prices ranging from $210.58 - $213.86. The price reported above reflects the weighted average sale price.
Includes 46.9596 shares of ResMed stock purchased on April 30, 2024, through the ResMed Employee Stock Purchase Plan.
Represents date options first became exercisable. Options vest 1/3 per year.
Michael J. Farrell, Chief Executive Officer
2024-06-10